A nervous system drug-by-design

By Science Blog Published at October 27, 2009 Views 65

Working like an architect, Prof. Hagit Eldar-Finkelman of Tel Aviv University's Sackler School of Medicine is "building" a new drug, L803-MTS, to treat a number of central nervous system (CNS) diseases like Alzheimer's. In pre-clinical studies, it also shows promise against Parkinson's, Huntington's and diabetes.

Read the full article at scienceblog.com

0

Likes

I like this I don't like this

Ask questions, get answers.
Give the community your two cents.
Be the first by adding your comments.